- Home
- LCTX vs HITI Comparison
LCTX vs HITI Comparison
Compare LCTX & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- HITI
- Stock Information
- Founded
- LCTX 1990
- HITI 2009
- Country
- LCTX United States
- HITI Canada
- Employees
- LCTX N/A
- HITI N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- HITI
- Sector
- LCTX Health Care
- HITI
- Exchange
- LCTX Nasdaq
- HITI Nasdaq
- Market Cap
- LCTX 166.3M
- HITI 188.0M
- IPO Year
- LCTX N/A
- HITI N/A
- Fundamental
- Price
- LCTX $0.91
- HITI $2.67
- Analyst Decision
- LCTX Strong Buy
- HITI Strong Buy
- Analyst Count
- LCTX 3
- HITI 1
- Target Price
- LCTX $5.67
- HITI $4.50
- AVG Volume (30 Days)
- LCTX 442.0K
- HITI 985.6K
- Earning Date
- LCTX 11-14-2024
- HITI 09-16-2024
- Dividend Yield
- LCTX N/A
- HITI N/A
- EPS Growth
- LCTX N/A
- HITI N/A
- EPS
- LCTX N/A
- HITI N/A
- Revenue
- LCTX $6,186,000.00
- HITI $370,017,302.00
- Revenue This Year
- LCTX N/A
- HITI $7.52
- Revenue Next Year
- LCTX $123.52
- HITI $13.35
- P/E Ratio
- LCTX N/A
- HITI N/A
- Revenue Growth
- LCTX N/A
- HITI 9.02
- 52 Week Low
- LCTX $0.77
- HITI $1.14
- 52 Week High
- LCTX $1.61
- HITI $3.12
- Technical
- Relative Strength Index (RSI)
- LCTX 55.63
- HITI 53.40
- Support Level
- LCTX $0.88
- HITI $2.47
- Resistance Level
- LCTX $0.97
- HITI $2.86
- Average True Range (ATR)
- LCTX 0.04
- HITI 0.18
- MACD
- LCTX 0.01
- HITI -0.05
- Stochastic Oscillator
- LCTX 71.56
- HITI 41.27
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.